Literature DB >> 19046990

IL4 blockade of inducible regulatory T cell differentiation: the role of Th2 cells, Gata3 and PU.1.

Suzana Hadjur1, Ludovica Bruno, Arnulf Hertweck, Bradley S Cobb, Benjamin Taylor, Amanda G Fisher, Matthias Merkenschlager.   

Abstract

Naive CD4 T cells differentiate into functionally distinct T helper (Th) cells subsets or into regulatory T (Treg) cells in response to the cytokine milieu in which they encounter antigen. A recurring theme in post-thymic CD4 T cell differentiation is the cross-regulation of lineage choice by cytokines and transcription factors that are expressed in alternative lineages. For example, TGFbeta induces the de novo expression of the Treg cell signature transcription factor Foxp3, but iTreg differentiation is blocked by high concentrations of the Th2 cytokine IL4. However, whether IL4 can antagonise Foxp3 induction in more physiological settings remains to be addressed. Here we use a co-culture system to demonstrate that IL4 provided by Th2 cells in vitro is sufficient to block Foxp3 induction in naive CD4 T cells. In addition, we find that Foxp3 induction is efficiently blocked not only by the Th2 transcription factor Gata3, but also by PU.1, which is transiently induced during Th2 differentiation. These data suggest that iTreg differentiation may be affected by the polarity of immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046990     DOI: 10.1016/j.imlet.2008.11.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  13 in total

Review 1.  The molecular mechanisms of Foxp3 gene regulation.

Authors:  Takashi Maruyama; Joanne E Konkel; Brian F Zamarron; WanJun Chen
Journal:  Semin Immunol       Date:  2011-07-12       Impact factor: 11.130

Review 2.  Immune mechanisms of oral immunotherapy.

Authors:  Michael D Kulis; Sarita U Patil; Erik Wambre; Brian P Vickery
Journal:  J Allergy Clin Immunol       Date:  2017-12-26       Impact factor: 10.793

3.  GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice.

Authors:  Elizabeth A Wohlfert; John R Grainger; Nicolas Bouladoux; Joanne E Konkel; Guillaume Oldenhove; Carolina Hager Ribeiro; Jason A Hall; Ryoji Yagi; Shruti Naik; Ravikiran Bhairavabhotla; William E Paul; Remy Bosselut; Gang Wei; Keji Zhao; Mohamed Oukka; Jinfang Zhu; Yasmine Belkaid
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

Review 4.  Plasticity of T reg at infected sites.

Authors:  E Wohlfert; Y Belkaid
Journal:  Mucosal Immunol       Date:  2010-03-17       Impact factor: 7.313

5.  Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy.

Authors:  Erik Wambre; Jonathan H DeLong; Eddie A James; Rebecca E LaFond; David Robinson; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2011-10-05       Impact factor: 10.793

Review 6.  Characterization of CD4+ T cell subsets in allergy.

Authors:  Erik Wambre; Eddie A James; William W Kwok
Journal:  Curr Opin Immunol       Date:  2012-08-10       Impact factor: 7.486

Review 7.  Effect of allergen-specific immunotherapy on CD4+ T cells.

Authors:  Erik Wambre
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-12

Review 8.  Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during immunopathological conditions.

Authors:  Joshua F Heiber; Terrence L Geiger
Journal:  Cell Immunol       Date:  2012-10-01       Impact factor: 4.868

9.  Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent.

Authors:  Sylvia Feyler; Gina B Scott; Christopher Parrish; Sarah Jarmin; Paul Evans; Mike Short; Katherine McKinley; Peter J Selby; Gordon Cook
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

10.  The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.

Authors:  Azlann Arnett; Keagan G Moo; Kaitlin J Flynn; Thomas B Sundberg; Liv Johannessen; Alykhan F Shamji; Nathanael S Gray; Thomas Decker; Ye Zheng; Vivian H Gersuk; Ziaur S Rahman; David E Levy; Isabelle J Marié; Peter S Linsley; Ramnik J Xavier; Bernard Khor
Journal:  Mol Cell Biol       Date:  2021-08-24       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.